Artificial Intelligence (AI) is transforming how we manage chronic diseases like diabetes and hypertension, making healthcare more precise and patient-focused. AI can analyze massive volumes of medical data using modern technologies such as machine learning (ML) and predictive modeling (PM), identifying trends, assisting in decision-making, and personalizing treatment plans. It is essential for early diagnosis, risk assessment, and remote monitoring, assisting doctors and patients in avoiding potential consequences. Chronic illnesses are a huge global health concern due to their extended duration and difficult management. Traditional treatments often fall short—delayed diagnoses, one-size-fits-all treatment plans, and poor patient adherence make it difficult to control these conditions effectively. In diabetes care, AI supports continuous glucose monitoring, predicts blood sugar fluctuations, and detects early signs of complications. For hypertension, AI enhances blood pressure monitoring, enhances risk assessment, and customizes medication strategies through predictive analytics. By integrating AI with real-time data and telemedicine, these technologies help bridge the gaps left by traditional treatments. Since the recent past, there has been an increase in dependence on AI in chronic disease management, making a shift toward precision medicine and more individualized care. However, the challenges are particularly regarding data privacy, ethical concerns, and the need for large, high-quality datasets. The integration of AI into existing healthcare systems, while guaranteeing data quality and regulatory compliance, is necessary for the long-term success. This review will explore the evolving role of AI in diabetes and hypertension management, focusing on predictive analytics, telemedicine, and personalized treatment strategies. Along with discussing how these advancements can improve patient outcomes, increase healthcare accessible, and build a more effective, patient-centered system, it will also address the ethical and technological challenges of using AI.